The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both?

PubWeight™: 0.79‹?›

🔗 View Article (PMID 27766242)

Published in Diabetes Metab J on September 27, 2016

Authors

Dora M Gorman1, Carel W le Roux2, Neil G Docherty3

Author Affiliations

1: Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, University College Dublin School of Medicine and Medical Sciences, Dublin, Ireland.
2: Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, University College Dublin School of Medicine and Medical Sciences, Dublin, Ireland.; Department of Gastrosurgical Research and Education, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Investigative Science, Imperial College London, London, UK.
3: Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, University College Dublin School of Medicine and Medical Sciences, Dublin, Ireland.; Department of Gastrosurgical Research and Education, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Articles cited by this

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 95.79

Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70

The pathobiology of diabetic complications: a unifying mechanism. Diabetes (2005) 14.96

Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med (2010) 10.75

Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med (2014) 10.66

Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. START INVESTS P 13. N Engl J Med (2016) 7.04

Diabetic retinopathy. N Engl J Med (2012) 5.79

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia (2001) 4.78

Retinopathy in diabetes. Diabetes Care (2004) 4.25

Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol (1998) 3.83

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA (2013) 3.49

Mechanisms of diabetic complications. Physiol Rev (2013) 3.41

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A (2000) 3.36

Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care (2000) 3.35

Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care (2003) 2.88

Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA (2014) 2.74

Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. Br Med J (Clin Res Ed) (1985) 2.01

Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet (2015) 1.65

Diabetic retinopathy. A clinical overview. Diabetes Care (1992) 1.61

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Diabetologia (2009) 1.59

Endothelial dysfunction - a major mediator of diabetic vascular disease. Biochim Biophys Acta (2013) 1.51

Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg (2014) 1.40

Insulin-like growth factors. Studies in diabetics with and without retinopathy. N Engl J Med (1983) 1.38

Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes Res Clin Pract (2013) 1.23

Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction. Am J Ophthalmol (2005) 1.15

Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes (1995) 1.11

Neurodegeneration: An early event of diabetic retinopathy. World J Diabetes (2010) 1.08

Diabetic glycemic control and retinal blood flow. Diabetes (1990) 1.05

Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg (2013) 1.02

Changes in diabetic retinopathy during pregnancy. Correlations with regulation of hyperglycemia. Arch Ophthalmol (1986) 1.01

Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes. Diabetes Care (2012) 1.00

Hyperglycemia impairs retinal oxygen autoregulation in normal and diabetic dogs. Invest Ophthalmol Vis Sci (1983) 0.99

Bariatric surgery and diabetic retinopathy: a pilot analysis. Obes Surg (2012) 0.99

Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabet Med (2013) 0.97

Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case-control study. Diabetologia (2015) 0.96

Effects of gastric banding on glucose tolerance, cardiovascular and renal function, and diabetic complications: a 13-year study of the morbidly obese. Surg Obes Relat Dis (2015) 0.88

Association of blindness to intensification of glycemic control in insulin-dependent diabetes mellitus. J Diabetes Complications (1994) 0.87

Progression of diabetic retinopathy after bariatric surgery. Diabet Med (2015) 0.87

Long-term remission of type 2 diabetes in morbidly obese patients after sleeve gastrectomy. Surg Obes Relat Dis (2012) 0.86

Monitoring of Diabetic Retinopathy in relation to Bariatric Surgery: a Prospective Observational Study. Obes Surg (2016) 0.85

Metabolic surgery: shifting the focus from glycaemia and weight to end-organ health. Lancet Diabetes Endocrinol (2014) 0.84

Effect of bariatric surgery versus intensive medical management on diabetic ophthalmic outcomes. Diabetes Care (2015) 0.83

The impact of bariatric surgery on retinopathy in patients with type 2 diabetes: a retrospective cohort study. Surg Obes Relat Dis (2015) 0.83

Roux-en-Y gastric bypass could slow progression of retinopathy in type 2 diabetes: a pilot study. Obes Surg (2015) 0.83

Does bariatric surgery adversely impact on diabetic retinopathy in persons with morbid obesity and type 2 diabetes? A pilot study. J Diabetes Complications (2013) 0.82

Diabetic retinopathy. Nutr Hosp (2013) 0.81

CLINICAL COURSE OF DIABETIC RETINOPATHY IN KOREAN TYPE 2 DIABETES AFTER BARIATRIC SURGERY: A Pilot Study. Retina (2015) 0.80

Bariatric and metabolic surgery and microvascular complications of type 2 diabetes mellitus. J Bras Nefrol (2015) 0.79

The Impact of Bariatric Surgery on Diabetic Retinopathy: A Systematic Review and Meta-Analysis. Obes Surg (2015) 0.79

Progression of retinopathy after improved metabolic control in type 2 diabetic patients. Relation to IGF-1 and hemostatic variables. Diabetes Care (1999) 0.78

Improved arteriole-to-venule ratio of retinal vessels resulting from bariatric surgery. Obesity (Silver Spring) (2012) 0.78

Bariatric surgery and microvascular complications of type 2 diabetes mellitus. Curr Atheroscler Rep (2014) 0.78

GLP-1 agonist treatment: implications for diabetic retinopathy screening. Diabetes Res Clin Pract (2011) 0.77

Advanced glycation end products and diabetic retinopathy. J Ocul Biol Dis Infor (2013) 0.77

Weight loss interventions and progression of diabetic kidney disease. Curr Diab Rep (2015) 0.76